Tissue distribution and clearance of intravenously administered titanium dioxide (TiO₂) nanoparticles

References

• Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, et al. 2004. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 77(2):347–357.
   PubMed Web of Science ®Google Scholar
• Borghoff S, Parkinson H, Leavens T. 2010. Physiologically based pharmacokinetic rat model for methyl tertiary-butyl ether; comparison of selected dose metrics following various MTBE exposure scenarios used for toxicity and carcinogenicity evaluation. Toxicology 275:79–91.
   PubMed Web of Science ®Google Scholar
• Cho MJ, Cho WS, Choi M, Kim SJ, Han BS, Kim SH, et al. 2009. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 189(3) 177–183.
   PubMed Web of Science ®Google Scholar
• Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, et al. 2001. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21(1):15–23.
   PubMed Web of Science ®Google Scholar
• Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. 2001. Ultrafine particles. Occup Environ Med 58(3):211–216.
   PubMed Web of Science ®Google Scholar
• Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, Ravenzwaay B. 2008. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch Toxicol 82:151–157.
   PubMed Web of Science ®Google Scholar
• Fuji Chimera Research Institute, Inc. 2009. Metallic Oxide 10. Ultrafine Particle Titanium Dioxide, Metallic Oxide 12. Titanium Dioxide for Photocatalyst, III. Market Compilation by Commodity Item, Current State and Future Outlook of the Ultrafine Particle Market in 2009. [Japanese]
   Google Scholar
• Kreyling WG, Wenk A, Behnke M. 2010. Quantitative biokinetic analysis of radioactively labelled, inhaled Titanium dioxide Nanoparticles in a rat model. Federal Environment Agency (Umweltbundesamt). http://www.umweltdaten.de/publikationen/fpdf-l/4022.pdf.
   Google Scholar
• Lankveld DPK, Oomen AG, Krystek P, Neigh A, Troost A, Noorlander CW, et al. 2010. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31:8350–8361.
   PubMed Web of Science ®Google Scholar
• Lesniak A, Campbell A, Monopoli MP, Lynch I, Salvati A, Dawson KA. 2010. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31:9511–9518.
   PubMed Web of Science ®Google Scholar
• Lu Y, Rieth S, Lohitnavy M, Dennison J, El-Masri H, Barton HA, et al. 2008. Application of PBPK modeling in support of the derivation of toxicity reference value for 1,1,1-trichloroethane. Regul Toxicol Pharm 50:249–260.
   PubMed Web of Science ®Google Scholar
• Lynch I, Dawson KA. 2008. Protein-nanoparticle interactions. Nanotoday 3(1–2):40–47.
   Web of Science ®Google Scholar
• Ma-Hock L, Burkhardt S, Strauss V, Gamer A, Wiench K, van Ravenzwaay B, et al. 2009. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhalation Toxicology 21(2):102–118.
   PubMed Web of Science ®Google Scholar
• Nakata K. 1994. Proliferation of alveolar macrophages. In: Takishima T editor. Basic and Clinical Aspects of Pulumonary Fibrosis. CRC Press, Boca Raton. pp133–146.
   Google Scholar
• Naito M. 2001. A basic information of macrophage 3. Distribution and form of macrophage. In: Takahashi K, Naito M, Takeya M, editors. Macrophage. Bunkodo Co. Ltd Tokyo, Japan. pp 13–31.
   Google Scholar
• Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Persp 113(7):823–839.
   PubMed Web of Science ®Google Scholar
• Pastino GM, Asgharian B, Roberts K, Medinsky MA, Bond JA. 1997. A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F1 mice, F344 rats, and humans. Toxicol Appl Pharmacol 145:147–157.
   PubMed Web of Science ®Google Scholar
• Peyret T, Poulin P, Krishnan K. 2010. A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals. Toxicol Appl Pharmacol 249:197–207.
   PubMed Web of Science ®Google Scholar
• Rehn B, Seiler F, Rehn S, Bruch J, Maier M. 2003. Investigation on the inflammatory and genotoxic lung effects of two types of titanium dioxide: untreated and surface treated. Toxicol Appl Pharmacol 189:84–95.
   PubMed Web of Science ®Google Scholar
• Sager TM, Kommineni C, Castranova V. 2008. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: Role of Particle surface area. Part Fibre Toxicol 5:17.
   PubMed Web of Science ®Google Scholar
• Sarin H. 2010. Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J Angiogenes Res 2:14.
   PubMedGoogle Scholar
• Shinohara N, Nakazato T, Tamura M, Endoh S, Fukui H, Morimoto Y, et al. 2010. Clearance kinetics of fullerene C60 nanoparticles from rat lungs after intratracheal C60 instillation and inhalation C60 exposure. Toxicol Sci 118(2):564–573.
   PubMed Web of Science ®Google Scholar
• Sugibayashi K, Todo H, Kimura E. 2008. Safety evaluation of titanium dioxide nanoparticles by their absorption and elimination profiles. J Toxicol Sci 33(3):293–298.
   PubMed Web of Science ®Google Scholar
• The Chemical Daily. 2010. Titanium dioxide: recovering demand due to the world market expansion (12 Sep. 2010).
   Google Scholar
• van Ravenzwaay B, Landsiedel R, Fabian E, Burkhardt S, Strauss V, Ma-Hock L. 2009. Comparing fate and effects of three particles of different surface properties: nano-TiO2, pigmentary TiO2 and quartz. Toxicol Lett 186:152–159.
   PubMed Web of Science ®Google Scholar
• Wang JX, Chen C, Liu YY, Jiao F, Li W, Lao F, et al. 2008. Potential neurological lesion after nasal instillation of TiO2 nanoparticles in the anatase and rutile crystal phases. Toxicol Lett 183(1–3):72–80.
   PubMed Web of Science ®Google Scholar
• Wang JX, Zhou GQ, Chen CY, Yu HW, Wang TC, Ma YM, et al. 2007. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 168:176–185.
   PubMed Web of Science ®Google Scholar
• Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM. 2007. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses to surface properties. Toxicology 230:90–104.
   PubMed Web of Science ®Google Scholar
• Xie G, Wang C, Sun J, Zhong G. 2011. Tissue distribution and excretion of intravenously administered titanium dioxide nanoparticles. Toxicol Lett 205(1):55–61.
   PubMed Web of Science ®Google Scholar
• Zhang L, Bai R, Li B, Ge C, Du J, Liu Y, et al. 2011. Rutile TiO2 particles exert size and surface coating dependent retention and lesions on the murine brain. Toxicol Lett 207(1):73–81.
   PubMed Web of Science ®Google Scholar